Briakinumab (Anti-IL-12) (IL-12a & IL-12b)

Briakinumab (anti-IL-12) (IL-12a & IL-12b) is a human monoclonal antibody directed against the human interleukins 12 (IL-12) and 23 (IL-23), with immunomodulating activity. It has the potential to be used in the treatment of Crohn's disease. MW: 143.86 KD.

• Supplier: Selleck Chemicals
• Product #: A2947
• Sku #: A2947-1mg*5